SSGSX
Price
$53.95
Change
-$0.26 (-0.48%)
Updated
Aug 10 closing price
Net Assets
4.51B
SSVIX
Price
$27.21
Change
-$0.14 (-0.51%)
Updated
Aug 10 closing price
Net Assets
416.19M
Interact to see
Advertisement

SSGSX vs SSVIX

SSGSX vs SSVIX Comparison Chart in %
View a ticker or compare two or three
VS
SSGSX vs. SSVIX commentary
Aug 11, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SSGSX is a Buy and SSVIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SSGSX has more cash in the bank: 4.51B vs. SSVIX (416M). SSVIX pays higher dividends than SSGSX: SSVIX (0.70) vs SSGSX (0.52). SSGSX was incepted earlier than SSVIX: SSGSX (27 years) vs SSVIX (25 years). SSGSX (1.23) is less costly to investors than SSVIX (0.98). SSGSX is a more actively managed with annual turnover of: 50.00 vs. SSVIX (20.00). SSVIX has a lower initial minimum investment than SSGSX: SSVIX (0) vs SSGSX (2500). SSVIX annual gain was more profitable for investors over the last year : 26.36 vs. SSGSX (23.17). SSVIX return over 5 years is better than : 6.57 vs. SSGSX (-1.30).
SSGSXSSVIXSSGSX / SSVIX
Total Expense Ratio1.230.91135%
Annual Report Gross Expense Ratio1.230.98126%
Fund Existence27 years25 years-
Gain YTD21.30225.97282%
Front Load6%N/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.51B416M1,085%
Annual Yield % from dividends0.520.7074%
Returns for 1 year23.1726.3688%
Returns for 3 years13.7017.7677%
Returns for 5 years-1.306.57-20%
Returns for 10 years41.1841.6299%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IOVA6.400.06
+0.95%
Iovance Biotherapeutics
BBIO84.670.19
+0.22%
BridgeBio Pharma
NRXS6.87-0.22
-3.10%
Neuraxis
BIAF0.49-0.02
-3.92%
bioAffinity Technologies Inc
NVEC118.36-7.58
-6.02%
NVE Corp